Current Report Articles
KHA Survey: Hospital Impact on 340B Program from Pharma Changes
340B (Sept. 25, 2020) – Recent actions taken by drug manufacturers have adversely impacted the 340B Prescription Drug Program. The Kansas Hospital Association has been engaged in many activities related to reverse the negative outcomes, including advocating for our U.S. House and Senate members to ask for action from the U.S. Department of Health and Human Services to halt some of the proposed actions by the drug manufacturers. In order to provide some quantitative data for our legislators, we ask you to complete a short survey about your 340B program and the impact these changes may have specific to you. Please complete this survey by Friday, Oct. 2. If you have questions, please contact Steve Poage or Audrey Dunkel at (785) 233-7436. Thanks!
--Steve Poage